Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial
Condition: Multidrug Resistant Tuberculosis Interventions: Drug: Bedaquiline; Drug: Pretomanid; Drug: Moxifloxacin; Drug: Linezolid; Drug: Clofazimine; Drug: Directly observed therapy (DOT) Sponsors: Medecins Sans Frontieres, Netherlands; University of Sussex; London School of Hygiene and Tropical Medicine; Doris Goodwin Hospitals, Kwazulu Natal, South Africa; Don McKenzie Hospitals, Kwazulu Natal, South Africa; Republican Scientific and Practical Centre for Pulmono logy and Tuberculosis hospital; Republican specialised scientific-practical medical centre, Tas...
Source: ClinicalTrials.gov - May 8, 2019 Category: Research Source Type: clinical trials